Release date: 16 March 2015
Promoter – Financial Intermediary
GRIFOLS SALocation
Description
The project covers the promoter’s research activities in the fields of plasma-derived therapies, diagnostics and medical solutions for hospitals.
Objectives
The project covers all stages of development i.e. pre-clinical development as well as clinical development. The project will be managed from the company’s headquarters in Barcelona, Spain.
Sector(s)
Proposed EIB finance (Approximate amount)
EUR 100 million
Total cost (Approximate amount)
Not disclosed.
Environmental aspects
The project mainly concerns investments in research and development (R&D) that are expected to be carried out in existing facilities already authorised for the same purpose and would therefore not require an environmental impact assessment (EIA) under Directive 2011/92/EU. Full environmental details will be verified during the appraisal.
Procurement
The promoter is a private company not operating in the Utilities sector and not having the status of a contracting authority. Thus it is not covered by EU directives on procurement. However, the promoter’s procurement procedures are expected to be in line with EIB guidelines for private-sector projects. The Bank’s services will verify details during the project due diligence.
Status
Signed - 28/10/2015
Disclaimer
Before financing approval by the Board of Directors, and before loan signature, projects are under appraisal and negotiation. The information and data provided on this page are therefore indicative.
They are provided for transparency purposes only and cannot be considered to represent official EIB policy (see also the Explanatory notes).